Gene Therapy in Treating Patients With Advanced Bladder Cancer
PHASE1CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
May 31, 1998
Primary Completion Date
December 31, 2002
Conditions
Recurrent Bladder CancerStage I Bladder CancerStage II Bladder CancerStage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
Interventions
BIOLOGICAL
Ad5CMV-p53 gene
Given intravesically
Trial Locations (1)
77030
M D Anderson Cancer Center, Houston
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00003167 - Gene Therapy in Treating Patients With Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter